Filing Flows › International Stem Cell (ISCO) › Capital expenditures
International Stem Cell (ISCO) capital expenditures by quarter
International Stem Cell's capital expenditures were $7K in Q2 2026 (second quarter 2026), -70% from Q1 2026. Over the last 5 quarters it ranged from $3K (Q4 2025) to $23K (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $7K | -70% | — |
| Q1 2026 | $23K | +667% | +360% |
| Q4 2025 | $3K | 0% | — |
| Q3 2025 | $3K | -40% | — |
| Q1 2025 | $5K | — | — |
Q2 2026 at a glance
International Stem Cell, Q2 2026: revenue $2.7M (+9% year over year), operating margin -1.3%, net loss $71K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
Questions
What is International Stem Cell's capital expenditures?
International Stem Cell's capital expenditures were $7K in Q2 2026 (second quarter 2026), -70% from Q1 2026.
How has International Stem Cell's capital expenditures changed?
Over the last 5 quarters it ranged from $3K (Q4 2025) to $23K (Q1 2026).
Q2 2026 results → · How International Stem Cell makes money →